Healthcare, Pharmaceuticals & Medical Devices

Gynecomastia refers to the proliferation of the glandular tissue in the male breast or the enlargement of the male breast. The major cause of gynecomastia is the hormonal imbalance which occurs between the estrogen level and androgen activity amongst the males. Several medications such as anti-androgens, anti-depressants, etc. are also associated with the cause of gynecomastia. Gynecomastia is common in infancy, puberty and middle-aged. The symptoms of gynecomastia include swelling, nipple discharge, pain, etc. Overuse of herbal products such as tea tree or lavender used in shampoo, soaps, and lotions are also associated with gynecomastia.

Increasing intake of alcohol is one of the major factor contributing towards the growth of gynecomastia treatment market. Intake of certain medications such as anti-depressants, anabolic steroids, etc. are the main cause of gynecomastia and are expected to increase the growth of gynecomastia treatment market. Various factors such as poverty, poor lifestyle habits lead to malnutrition, which can drive the gynecomastia market. Increasing healthcare awareness is also expected to increase the growth of gynecomastia treatment market. The increasing prevalence of liver and kidney disorders such as liver cirrhosis, liver failures, kidney failures are expected to boost the gynecomastia treatment market. Increasing geriatric population is another factor which can contribute to the growth of gynecomastia treatment market. The geriatric population is prone to hormonal changes that occur with normal aging and can cause gynecomastia. Increasing sports and physical activities can also lead to the growth of gynecomastia treatment market as sports person or teenagers engaged in various physical activities, are expected to take anabolic steroids in a large quantity, to enhance the athlete performance, and can ultimately increase the growth of gynecomastia treatment market.

Lack of awareness in some emerging regions or rural areas is a factor which can hamper the growth of gynecomastia treatment market. Unavailability of medications is another factor which can restrain the growth of gynecomastia treatment market. The global Gynecomastia Treatment market is segmented on basis of treatment type, end user and geographic region: 

• Segmentation by Treatment Type
  • Drugs
    • Tamoxifen
    • Raloxifene
    • Aromatase Inhibitors
    • Others
• Surgical Treatment 
  • Segmentation by End User
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Drug Stores
    • Online Pharmacies

Based on the product type, the Gynecomastia Treatment market has been segmented into drugs and surgeries. The medications used for the treatment of gynecomastia include tamoxifen, Raloxifene, Aromatase Inhibitors, and other medications. Tamoxifen is generally taken for the treatment of severe gynecomastia. Based on the end user, the gynecomastia treatment market has been segmented into hospital pharmacies, retail pharmacies, drug stores, and online pharmacies. Hospital pharmacies and retail stores are expected to hold the largest revenue share in the gynecomastia treatment market.

Based on geography, the global Gynecomastia Treatment market has been divided into a few main regions, which includes North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa. North America, is expected to register large revenue shares in global Gynecomastia Treatment market because of the advanced healthcare infrastructure and easy availability of treatment facilities. Europe is expected to hold the second largest market share because of the increasing geriatric population. The Asia Pacific can also show a large revenue share in the Gynecomastia Treatment market because of the increasing healthcare awareness amongst the people and increasing research and developmental activities

There are many pharmaceutical companies manufacturing gynecomastia treatment drugs. Some of the big pharmaceutical companies involved in the manufacture of Gynecomastia Treatment are Cadila Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd., Zydus Cadila Healthcare Ltd., Biochem Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd.etc.,.

The report covers exhaustive analysis on:

• Gynecomastia Treatment Market Segments
• Gynecomastia Treatment Market Dynamics
• Historical Actual Market Size, 2013 – 2017
• Gynecomastia Treatment Market Size & Forecast 2018 to 2026
• Gynecomastia Treatment Market Current Trends/Issues/Challenges
• Competition & Companies involved
• Gynecomastia Treatment Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• Asia Pacific Excluding China
• China
• Middle East & Africa 

Report Highlights:

• Shifting Industry dynamics
• In-depth gynecomastia treatment market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Biopsy is a most common procedure which is used to remove a section of cells or tissue from the body. It is the most precise and accurate procedure for identifying or detecting malignancies. Biopsy can be categorized into excisional biopsy, incisional biopsy, aspiration biopsy and punch biopsy. Breast biopsy is also a procedure whereby the breast tissues are being removed to examine if there is any sort of indications of breast cancer. Breast biopsies are mostly conducted by minimal invasive biopsy system owing to reduction in pain and disfigurement. Breast biopsy marker is a piece of small tiny stainless steel or titanium marker which is used to identify the area where the breast tissue was removed. Br east biopsy marker has been proven to be safe and effective in biopsy procedure.  According to American Institutes for Cancer Research report, over two million new cases were recorded U.S. in 2018.

The global breast biopsy markers market is expected to register substantial growth in the market owing to increase in prevalence of breast cancer among women and rising campaigns in creating awareness among women about breast cancer is likely to propel the growth of the breast biopsy markers market. In addition to this, rising reimbursement for the biopsy procedure and increasing demand for less invasive breast biopsy markers procedure is another factor adding to the growth of the breast biopsy markers market. However, there are certain limitations of breast biopsy markers. The breast biopsy markers may causes pain, rashes and allergies to the individuals. Moreover, the titanium used in breast biopsy markers may not be pure and may lead to contamination. All these complications impact the adoption of breast biopsy markers which may hamper the growth of the breast biopsy markers market. With the advancement in surgical procedure, the breast biopsy markers will foster the growth of the market. Currently, Vacuum-assisted core biopsy is gaining more popularity in breast biopsy markers market due to its safety and minimally invasive procedure. In addition to this, it provide accurate diagnosis and remove the lesion completely under real-time ultrasonic guidance.

The global breast biopsy markers market is segmented on the basis of material type, shape types and end user

• Breast Biopsy Markers Market Segmentation by Material
  • Nitinol
  • Titanium
  • Stainless steel
• Breast Biopsy Markers Market Segmentation by Shape
  • Open Coil
  • Butterfly
  • Barrel
  • U-shape
  • Bowtie
  • Triple twist
  • Barbell
  • Tribell
  • Anchor
• Breast Biopsy Markers Market Segmentation by End User
  • Hospitals
  • Ambulatory surgical centers
  • Cancer clinics
  • Cancer research laboratories
  • Diagnostics centers

Geographically, breast biopsy markers market is categorized into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to hold the largest revenue share in breast biopsy markers market owing to advanced and early adoption of new technologies. According the US Breast Cancer statics, an estimate of 268,800 new cases is diagnosed in US in 2019. Increase in healthcare infractutre and government healthcare spending, the region is likely to contribute significant growth in the breast biopsy markers market. Europe accounts to have considerable share in breast biopsy markers due to increasing prevalence of the cancer and rising aging population. Asia Pacific seems to have increasing potential in breast biopsy markers market due to rising disposable income and increasing awareness among people about breast biopsy markers and breast cancer which as a result the overall breast biopsy markers will have increase in the market. Middle East and Africa shown to have less growth in the market owing to less adoption of new technologies and lack of proper healthcare facilities which may hinder the growth of the breast biopsy markers market.

Some of the key players leading in breast biopsy markers market are: Hologic Inc, Argon Medical Devices, Inc., Somatex Medical Technologies GmbH, Vigeo srl, Medsurge Ind Private Limited, TRA Medical Imaging, Cigna, Trivitron Healthcare, Johnson & Johnson Services, Inc, Biocept, Inc. Breast-Med, Inc., C.R. Bard, Inc. Leica Biosystems.

The report covers exhaustive analysis on:

• Breast Biopsy Markers Market Segments
• Breast Biopsy Markers Market Dynamics
• Historical Actual Market Size, 2014 – 2018
• Breast Biopsy Markers Market Size & Forecast 2019 to 2029
• Breast Biopsy Markers Agents Current Trends/Issues/Challenges
• Competition & Companies involved
• Breast Biopsy Markers Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies for key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Fine needle biopsy has been used to determine palpable breast with imaging technology and also to identify non-palpable breast by use of ultrasound and stereotaxy. Certain limitations in fine needle biopsy such as lack of ability to identify between in situ and invasive cancer has made less usage of this procedure. Thus, vacuum-assisted breast biopsy systems was introduced to the market. Vacuum-assisted breast biopsy systems is a device that is being developed for the biopsy of non-palpable lesions. Vacuum-assisted breast biopsy systems has several advantages over fine needle biopsy such as it allows removal of multiple large tissue samples in a single insertion by reducing errors. Vacuum-assisted breast biopsy is a widely used procedures for patients with palpable masses of breast or breast abnormality.

The global vacuum assisted breast biopsy systems market is expected to manifest substantial growth in the market since it has proven to be effective, feasible and safe technology. Due to its minimally invasive, vacuum assisted breast biopsy systems has been widely used for removal of benign breast lesions without any severe complications. In addition to this, vacuum assisted breast biopsy systems has increased in frequency in detecting the noninvasive malignant breast lesions which as a result it has gain much popularity among the other cancer detection systems available in the market. Vacuum-assisted breast biopsy systems has the capacity of tissue acquisition in every 4.5 seconds lasting less than 30 seconds. Moreover, vacuum-assisted breast biopsy device and tubing can be disposed fully and reduces the  maintenance. Apart from this, vacuum assisted breast biopsy systems is an accurate technology for the diagnosis, sampling and early identification of breast cancer which as a result, the  vacuum assisted breast biopsy systems seems to have significant growth in the market. However, there occurs certain limitation of vacuum assisted breast biopsy systems. The cost of vacuum assisted breast biopsy systems is much higher than the other biopsy systems. Also, it require repeated probe insertions in every collection of samples which increases the time and the accuracy. This factor may hinder the growth of the vacuum assisted breast biopsy systems market.

The global vacuum assisted breast biopsy systems market is segmented on the basis of technology types, and end user

• Vacuum Assisted Breast Biopsy Systems Market Segmentation by Technology
  • Stereotactic vacuum assisted breast biopsy systems
  • Ultrasound-guided core needle vacuum assisted breast biopsy systems
  • MRI-guided core needle vacuum assisted breast biopsy systems
• Vacuum Assisted Breast Biopsy Systems Market Segmentation by End User
  • Hospitals
  • Ambulatory surgical centers
  • Diagnostics centers
  • Cancer clinics
  • Cancer research laboratories

Geographically, vacuum assisted breast biopsy systems market is categorized into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to contribute the substantial growth in vacuum assisted breast biopsy systems market owing to advancement in technology and high adoption of new techniques. According the US Breast Cancer statics report, an estimate of 268,800 new cases is diagnosed in US in 2019. Increase in healthcare facilities and government healthcare spending, the region is likely to spur significant growth in the vacuum assisted breast biopsy systems market. Europe accounts to have considerable share in vacuum assisted breast biopsy systems due to increasing in rising aging population and increase in prevalence of the cancer. Asia Pacific has increasing potential in vacuum assisted breast biopsy systems market due to increasing demand for new technologies, rising disposable income and increasing awareness among people about vacuum assisted breast biopsy systems which as a result the overall vacuum assisted breast biopsy systems will have increase in the market. Middle East and Africa shown to have minimal growth in the market due to lack of proper healthcare infrastructure and less adoption of new technologies which may hinder the growth of the vacuum assisted breast biopsy systems market.

Some of the key players leading in vacuum assisted breast biopsy systems market are: C.R. Bard Inc, Hologic Inc., SenoRX, Inc., Medsurge Ind Private Limited, Devicor Medical Products, Inc.

The report covers exhaustive analysis on:

• Vacuum Assisted Breast Biopsy Systems Market Segments
• Vacuum Assisted Breast Biopsy Systems Market Dynamics
• Historical Actual Market Size, 2014 – 2018
• Vacuum Assisted Breast Biopsy Systems Market Size & Forecast 2019 to 2029
• Vacuum Assisted Breast Biopsy Systems Current Trends/Issues/Challenges
• Competition & Companies involved
• Vacuum Assisted Breast Biopsy Systems Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies for key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Fat transfer procedure is a procedure that uses a person’s own fat to fill in irregularities and grooves. This procedure can also be called as the micro-lipo injection or autologous facial fat injections. Liposuction refers to the extraction of fat and then the fat is transferred to the face. There are various applications of facial fat injections, which include correction of facial shape, reductions of scars and wrinkles, enhancement of lips, removal of the double chin and many more.

The increasing demand for non- invasive diagnostic procedures, is one of the major factor driving the growth of the facial fat injections market. Among the Aesthetic procedures performed worldwide the demand for Non-invasive procedure is more and is rising at double digits. Less complexity of the procedure, the possibility for reversal of the procedure, less time taken for procedure comparing to the surgical aesthetic procedure has increased the demand for non-invasive aesthetic procedures and eventually for facial Injectable procedures. According to AASPS, around 15.1 million aesthetic procedures were performed in 2013 among which approximately 87% were non-invasive  There are multiple applications of facial fat injections such as acne reduction, wrinkles removal enhancement of lip size, etc., which can drive the facial fat injections market. The increasing disposable income and increasing beauty awareness are also responsible to increase the growth of the facial fat injection market. Facial fat injections do not cause an allergic reaction, and hence, the number of people are inclining towards facial fat injections. The increasing number of aesthetic surgeons and authorization, performing the aesthetic procedures are increasing, which can drive the facial fat injections market. Increasing no of plastic surgeons and their network is driving the demand for aesthetic procedures and which in turn is boosting the facial fat injections market. Other factors such as increasing research and developmental activities, increasing pollution, increasing number of aesthetic surgeries can boost the facial fat injections market. Influence of social media regarding facial injectable and an increasing number of facial fat transfer hospitals can increase the growth of the facial fat injections market. 

Side effects associated with facial fat injections such as swelling is expected to decrease the growth of facial fat injections market. The high cost of aesthetic surgeries and procedures can also hamper the growth of the facial fat injections market.  

The global Facial Fat Injections market is segmented on the basis of application, end user, and geography:

• Segmentation by Application
  • Wrinkle Removal
  • Scars Removal
  • Facial shape modifications
  • Lips Enhancement
  • Others
• Segmentation by End User
  • Hospitals
  • Specialty Clinics
  • Spa & Beauty Clinic

Based on the application, the Facial Fat Injections are segmented into wrinkle removal, scars removal, facial shape modification, lips enhancement, and others. Facial shape modifications are expected to hold the maximum revenue share in the facial fat injections market. Based on the end user, the facial fat injections market has been segmented into hospitals, specialty clinics, and spa & beauty clinics. Spa & beauty clinic is expected to hold the maximum share in the overall facial fat injections market.

Regionally, the global facial fat injections market is segmented into five key regions viz. North America, Latin America, Europe, Middle East & Africa and the Asia Pacific. North America is expected to contribute a major revenue share in the global facial fat injections market owing to the growing number of facial surgical and injectable procedures to improve physical presence. Europe also shows the high growth rate in the facial fat Injections market due to the presence of a large population. Facial fat injections market in the Asia-Pacific region is expected to witness significant growth rate in the coming years due to increasing disposable income and increasing beauty awareness amongst the people.

Some of the players identified in the global Facial Fat Injections market are ALLERGAN, SciVision Biotech Inc., Galderma S.A., Sanofi, Sinclair Pharma, Valeant Pharmaceuticals, etc.

The report covers exhaustive analysis on:

• Facial Fat Injections Market Segments
• Facial Fat Injections Market Dynamics
• Historical Actual Market Size, 2013 – 2015
• Facial Fat Injections Market Size & Forecast 2016 to 2024
• Facial Fat Injections Agents Current Trends/Issues/Challenges
• Competition & Companies involved
• Facial Fat Injections Market Drivers and Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth facial fat injections market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies for key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Desmoid tumor is a rare condition where tumor develops in the fibrous or connective tissue present in the body. Most observations has led to a conclusion that desmoid tumors are more visible in the t tendons and ligaments, usually in the legs, midsection and arms, and also desmoid tumor can be found in the sections of the head and neck. There can be a wide range of clinical symptoms associated with desmoid tumor treatment. Symptoms like rupture of intestines, severe pain, bloating, compression of the kidneys or ureters or rectal bleeding. Desmoid tumor treatment starts with proper diagnosis methods which include ultrasound, MRI and/or CT scans. First line desmoid tumor treatment include real time observation of the patent collecting all range of behaviors. Desmoid tumor treatment include medical procedures to kill the tumor or surgically remove the tumor, the desmoid tumor treatment also include medication to support the procedure.

The global market for desmoid tumor treatment is probable to be attractive over the forecast, the main growth factors include cases that are reportedly growing at a significant rate. Desmoid tumors are reported to constitute 0.03% of all cancers. Though, desmoid tumor is not associated with cancer, but there is a slight chance of diagnosing with cancer if you have desmoid tumor. Investigation and research over new and best form of medication is performed, the developments for desmoid tumor treatment in research phase plays an important role in expanding the market size. Desmoid tumor treatment is growing in terms of target drug development and big scale manufacturing, also major companies have their range of products in clinical phases. Massive investments from the pharmaceutical businesses will allow more number of research with expanded therapeutic line for desmoid tumor treatment. As the presence of generic drugs in new age desmoid tumor treatment limit the market revenue due to reference pricing.  Most of the products are distributed through prescriptions. Distribution of such desmoid tumor treatment controls the entire market structure and channel a predictable growth 

The global market for Desmoid Tumor Treatment is segmented on the basis of Product Type, End User and Geography:

Desmoid Tumor Treatment Market Segment by Treatment Type

• Medical Procedure
  • Radiation Therapy
  • Thermal Ablation
  • Chemotherapy
• Medication
  • Anti-inflammatory Medication
  • Hormone Therapy
  • Tyrosine Kinase Inhibitors
  • Others

Desmoid Tumor Treatment Market Segment by End User

• Hospital
• Clinic
• ASCs
• Home care Setting
• Academic Research Center
• Private Laboratory

The global desmoid tumor treatment market is segmented by product type, end user and geography. Based on product type, the global desmoid tumor treatment market is segmented into Medical Procedure and medication. Patient with desmoid tumor happens to take medication if they are sensitive towards medical procedures involving surgery or radiation, medication include anti-inflammatory medication, hormone therapy, tyrosine kinase inhibitors and others. Anti-hormonal medicines are most vividly used and the respective segment takes a significant market share in the global desmoid tumor treatment market.

On the basis of geography, global desmoid tumor treatment market is segmented into seven significant regions viz. South Asia, East Asia, North America, Latin America, Europe, Middle East & Africa and Oceania. North America is the biggest market in terms of revenue for desmoid tumor treatment, the scenario is due to progressive investments for medications and suitable availability of quality facilities. Europe along with East Asia comprise many global and regional manufacturers for desmoid tumor treatment. Government initiatives to lower the prices for each drug type is observed in these region, also the affective R&D present in this region compliments the market structure for desmoid tumor treatment. Middle East and Africa is the least attractive market for desmoid tumor treatment, and coupled with slow development present it is projected to have a similar scenario in future.

Globally the market for desmoid tumor treatment is consolidated with few players and also includes many regional generic manufacturers. Some of the key players operating in the desmoid tumor treatment market include Novartis AG, Amgen Inc., Abbott Laboratories, AbbVie Inc., Bayer AG, Stryker Corporation, Beckman Coulter Inc., Debiopharm Group, and F. Hoffmann-La Roche Ltd.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Historical Actual Market Size, 2013- 2017
• Market Size & Forecast 2018 to 2028
• Market Current Trends/Issues/Challenges
• Competition & Companies Involved
• Market Drivers And Restraints

Regional analysis includes

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Report Highlights:

• Shifting Industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size Recent industry trends
• Key Competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance

Radiation Tattoo Markers are the temporary or permanent tattoo markings utilized to guide the radiation therapy in treatment of cancer. The tattoo ink utilized in the markings are of non-reactive nature, and are inert with tissue surroundings. The ink type are usually classified according to the color of the ink and associated dye type. Whether the dye uses Florence or not is totally dependent on the associated Florence chemical entity listed in the dye. Many a time the treatment with the radiation therapy require a repetitive sessions and additional requirement of therapy session with different drug. Which increases the demand for the radiation tattoo markers. Radiation delivery in cancer treatment is an important factor in image guided therapy and image guided therapy planning. The radiation tattoo markings aids in achieving the accuracy and reproducibility of the treatment delivery. The radiation tattoo markers are one of the primary aspect in delivering targeted radiation treatment. 

Radiation Tattoo Markers Market: Drivers and Restraints

Radially increasing cancer research studies and growing incidence of cancer in humans. Research on the development of the dedicated Florence dye for Radiation Tattoo Markers following with increasing availability of blue ink Radiation Tattoo Markers. Is expected to fuel the Radiation Tattoo Markers market. Furthermore, raising awareness on cancer treatment, radiation planning and minimalistic markings of Radiation Tattoo Markers is signifying the growth of the Radiation Tattoo Markers market. The surge in the cancer incidence and prevalent population is estimated to positively affect the growth of the Radiation Tattoo Markers market. The increasing incidence rate for melanoma skin cancer and non-melanoma skin cancer is anticipated to propel the growth of the radiation tattoo markers market. The essentiality of the Radiation Tattoo Markers in effective radiation therapy planning is anticipated to offer lucrative growth opportunities in the Radiation Tattoo Markers Market. However, uneasy procedure of tattooing and taboo associated with Radiation Tattoo Markers and constant remainder of disease association with tattoo is anticipated the restraint the growth of the Radiation Tattoo Markers market.

Radiation Tattoo Markers Market: Segmentation

Based on Product Type, the Radiation Tattoo Markers market is segmented into:

• Black Ink Tattoo
• Blue Ink Tattoo
• UV Ink Tattoo

Based on End User Tattoo Markers market is segmented into:

• Radiation Centers
• Cancer Research Centers
• Hospitals

Radiation Tattoo Markers Market: Overview

The radiation markers preassembles the displays the domination of few manufacturers and are commonly focused on development of non-reactive inks for the radiation tattoo markings and working towards the development of Florence dyes to reduce the uncomfortable feeling associated with the after surgery symptoms and association of uneasy feeling. The manufacturers are constantly working on the associated techniques making radiation tattoo a less painful procedure. The manufacturers in the radiation tattoo markers market are constantly developing a possible solution for the minimizing the color intensity utilized in the tattoo ink. Wolf X-Ray Flow have come up with an invisible ink marking in the tattoo, in the product offering SteriTatt were adopted the product adopt the color less ink having properties of the florescence and emits fluoresce while under the ultraviolet light. The rising adoptions of the radiation therapy in the treatment of cancer is anticipated to propel the demand for radiation tattoo markers. Thereby fueling the growth of the Radiation tattoo markers market. Due to the wide array of tattoo dyes available for tattoo the market is highly fragment with presence of small players in the market. 

Radiation Tattoo Markers Market: Region-Wise Overview

The global Radiation Tattoo Markers market is segmented into the following regions – North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa. North America is the prominent regional market for Tattoo Markers due to the increasing incidence of life-threatening cancer and growing adoption of the radiation therapy for the treatment of cancer. Additionally availability of technologically advanced Radiation Tattoo Markers and inks demand in the region.

In Europe, Germany and UK. Are prominent market for the radiation tattoo markers is dominating Radiation Tattoo Markers market due to increasing awareness for cancer treatment and rising awareness about the available treatment in the country. Latin America Radiation Tattoo Markers market is anticipated to grow at low rates due to the comparative less awareness in the region.

South Asia is a growing at significant rate owing to growing awareness in care givers and radiation technicians about Radiation Tattoo Markers. Growth in Middle East and Africa is considerably low due to low incidence rate and higher taboo association in the regions.

Radiation Tattoo Markers Market: Key Participants 

Examples of some of the key participants in the Radiation Tattoo Markers market are Wolf X-Ray Flow., Biotic Phocea, Eternal Ink, Inc, Intenze Products Inc, and Dynamic Color among others. 

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

• Radiation Tattoo Markers Market Segments
• Radiation Tattoo Markers Market Dynamics
• Radiation Tattoo Markers Market Size
• Radiation Tattoo Markers Market Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

The regional analysis includes:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

• A detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current, and projected market size regarding volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies for key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analyst. They do not necessarily reflect formal positions or views of RRI.

Cardiovascular CT: Market Insights

Cardiovascular CT is a scanner which is used to diagnose cardiovascular disease. Cardiovascular CT produces detailed pictures of the heart and the blood vessels. Cardiovascular CT is used to scan the arteries and diagnose the disease associated with the heart, by the use of radiations. Cardiovascular CT procedure can be performed in a hospital or any medical imaging facility. Cardiovascular CT usually takes fifteen minutes to complete. Before the cardiovascular CT test, a contrast dye, usually iodine is inserted into the veins of the patient. The contrast dye highlights the veins and helps to produce clear and better pictures. A cardiovascular CT is a tunnel-like machine, which has a table. The patient lies on the table and the table slides in the scanner. During a cardiovascular CT procedure, the heart rate of the patient is monitored.

The manufacturing companies are focusing to launch new products in the cardiovascular CT market. For example – In April 2018, new coronary imaging system, by GE Healthcare, has been introduced in the cardiovascular CT market. Also, Aquilion Precision, manufactured by Canon has been launched in the cardiovascular CT market. 

The companies are also involved in acquisitions and mergers. For Instance – In 2019, Siemens joined GE Healthcare for the launch of cardiovascular CT Scanner..

Cardiovascular CT: Market Dynamics

The increasing prevalence of coronary heart disease is one of the major factor driving the growth of cardiovascular CT market. The technological advancement of products is expected to increase the growth of cardiovascular CT market. High adoption of poor lifestyle habits, can also be responsible for the growth of cardiovascular CT market. Other various factors such as increasing geriatric population, increasing healthcare awareness, etc. can increase the growth of the market.

There are various allergic reactions associated with the insertion of contrast dye, which can hinder the growth of cardiovascular CT market. Also, a patient can face breathing problems because of the introduction of some drugs which slows down the heart rate. This factor can hinder the growth of the cardiovascular CT market.

The increasing prevalence of coronary heart disease is one of the major factor driving the growth of cardiovascular CT market. The technological advancement of products is expected to increase the growth of cardiovascular CT market. High adoption of poor lifestyle habits, can also be responsible for the growth of cardiovascular CT market. Other various factors such as increasing geriatric population, increasing healthcare awareness, etc. can increase the growth of the market.

There are various allergic reactions associated with the insertion of contrast dye, which can hinder the growth of cardiovascular CT market. Also, a patient can face breathing problems because of the introduction of some drugs which slows down the heart rate. This factor can hinder the growth of the cardiovascular CT market.

Cardiovascular CT Market: Segmentation

The Cardiovascular CT market is segmented by Product type and End User:

• Segmentation by Product Type
  • Electron Beam Cardiovascular CT
  • Multi-detector Cardiovascular CT
• Segmentation by End User
  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics 

Cardiovascular CT Market: Overview

On the basis of product type, the cardiovascular CT market has been segmented into electron beam cardiovascular CT and Multidetector Cardiovascular CT. Electron beam cardiovascular CT is used to create a calcium score which helps to electron beam cardiovascular CT to treat the calcium deposits in the coronary arteries. Multi-detector cardiovascular CT work very fast and detailed. Electron beam cardiovascular CT is expected to hold the maximum revenue share in the cardiovascular CT market. Based on the end user, the cardiovascular CT market has been segmented into hospitals, diagnostic laboratories, and specialty clinics. Hospitals are expected to hold the maximum revenue share in the cardiovascular CT market. 

Cardiovascular CT Market: Region-wise Outlook

On the basis of geography, global Cardiovascular CT market has been fragmented into several key regions i.e.  North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. North America is expected to hold the largest shares in the global Cardiovascular CT market because of the presence of well- established healthcare infrastructure and high prevalence of obesity, which is responsible for the occurrence of cardiovascular diseases. Europe is expected to hold the second largest share in the cardiovascular CT market because of the presence of large population. Asia-Pacific is expected to hold a large revenue share in the cardiovascular CT market because of the increasing awareness amongst the people and high adoption of poor lifestyle habits such as intake of junk food, lack of exercise etc.   

Cardiovascular CT Market: Key Players

Some of the key players present in global Cardiovascular CT market are GE Healthcare, Canon Medical Systems Corporation, Vital Images, Siemens Healthcare GmbH, Hitachi, Ltd., Koninklijke Philips, Medviso etc. 

The report covers exhaustive analysis on:

• Cardiovascular CT Market Segments
• Cardiovascular CT Market Dynamics
• Cardiovascular CT Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance

Endotracheal suctioning devices are classified under the respiratory suctioning devices. Endotracheal suctioning devices are broadly used to remove saliva and thick mucus along with other secretions from the trachea, mouth or the lower airway. These endotracheal suctioning devices are used on patients who finds it difficult to mobilize their secretions. A large patient pool suffering with neuromuscular disease, neurological deficits or sedation are unable to clear their own airway. Also, intubated patients with an artificial airway creates a huge demand for endotracheal suctioning devices while being on a ventilator. The endotracheal suctioning devices works on two suctioning techniques, known as the closed and open system. It is necessary that endotracheal suctioning devices should be handled by skilled personnel with appropriate care. The endotracheal suctioning devices has found to register both therapeutic and diagnostic benefits. The other equipment used with endotracheal suctioning devices include endotracheal suction catheter, tubes, suction apparatus, endotracheal cannula, monitoring equipment, along with oxygen source and others.

Endotracheal Suctioning Devices Market: Drivers and Restraints

An increase in endotracheal suctioning procedures has been recorded over the last few years in wide variety of settings such as hospitals, outpatient clinics, transport vehicles, trauma centers, ambulatory surgical centers and others. This creates robust revenue opportunities for new entrants to enhance their sales by offering products for various end use settings across the globe and is anticipated to be leading factor aiding revenue growth in endotracheal suctioning devices market. The introduction of innovative endotracheal suctioning devices such as closed tracheal suctioning system that eradicates the need for disconnecting patient from ventilator during endotracheal suctioning procedure, supports heavy revenue growth in global endotracheal suctioning devices market. There has been increased demand for endotracheal suctioning devices that offers high patient care along with safety all together. The introduction of easy-to-use endotracheal suctioning devices with most advanced airway supervision innovation further aids the new revenue generation in global endotracheal suctioning devices market. However, a number of complications associated with usage of endotracheal suctioning devices such as hypoxemia, pneumonia, bradycardia, blood pressure fluctuations, ETT dislodgement and others may suppress the growth of endotracheal suctioning devices market. Also, high prices of endotracheal suctioning devices also obstructs the revenue growth in endotracheal suctioning devices market.

Endotracheal Suctioning Devices Market: Segmentation

The global endotracheal suctioning devices market is classified on the basis of product type, disease indication, suction type, end user and region.

Based on product type endotracheal suctioning devices market is segmented into following:

• Open-Suction Device
• Closed-Suction Device
• Suction Catheters

Based on disease indication endotracheal suctioning devices market is segmented into following:

• Desaturations
• Bradycardia
• Tachycardia
• Neurological Deficits
• Respiratory Failure
• Others

Based on suction type endotracheal suctioning devices market is segmented into following:

• Shallow Suction
• Deep Suction

Based on end user endotracheal suctioning devices market is segmented into following:

• Hospitals
• Extended Care Facilities
• Trauma Centers
• Homecare Settings
• Ambulatory Surgical Centers
• Rehabilitation Centers

Endotracheal Suctioning Devices Market: Overview

The endotracheal suctioning devices market, on the basis of product type has been categorized into suction catheters, open-suction devices and closed-suction devices. Among these endotracheal suctioning devices, closed-suction endotracheal suctioning devices followed by open-suction endotracheal suctioning devices dominates the endotracheal suctioning devices market and is expected to maintain its dominance over the forecast period. However, based on the suction type, deep suction procedures are most widely performed procedures using endotracheal suctioning devices over the shallow suctioning procedures, thus accounting for majority of revenue share in global endotracheal suctioning devices market. Based on the end user, hospitals followed by ambulatory surgical centers and trauma centers accounts to be prominent end use segment in global endotracheal suctioning devices market on the account of increasing number of endotracheal suctioning procedures performed.

Endotracheal Suctioning Devices Market: Regional Overview

Among the regional presence, North America followed by Europe is projected to offer lucrative market opportunities to the new entrants in endotracheal suctioning devices market. North America registers high revenue generation due to the presence of large manufacturing base for endotracheal suctioning devices in the region. North America and Europe altogether accounts for a significant market share in terms of value in endotracheal suctioning devices market. However, due to high prevalence for diseases such as respiratory failures, desaturations and neurological deficits, along with strong preference for endotracheal suctioning devices over other airway management systems allows South Asia followed by East Asia region to register third largest revenue share in global endotracheal suctioning devices market. However, Middle East and Africa is expected to register slow growth in endotracheal suctioning devices market due to lack of skilled professionals to perform endotracheal suctioning procedures in hospitals.

Endotracheal Suctioning Devices Market: Key Players

Some of the major endotracheal suctioning devices manufacturers present across the globe are Intersurgical Ltd, Vitaltec Corporation., Flexicare Medical Limited., Halyard Health, Inc., ENDOCLEAR LLC, Shandong Steve Medical Science & Technology Co. Ltd. and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report on Endotracheal Suctioning Devices Market covers exhaust analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Indication
• Value Chain

Regional analysis for Endotracheal Suctioning Devices Market includes:

• North America (U.S., Canada)
• Latin America (Mexico, Brazil, Argentina, Chile, Peru, rest of Latin America)
• Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
• East Asia (China, Japan, South Korea, Rest of East Asia)
• South Asia (India, Malaysia, Thailand, Indonesia Rest of South Asia)
• Oceania (Australia, New Zeeland)
• Middle East and Africa (GCC, S. Africa, Turkey, Iran, Israel, Rest Of MEA)

The report on Endotracheal Suctioning Devices Market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report on Endotracheal Suctioning Devices Market provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report on Endotracheal Suctioning Devices Market also maps the qualitative impact of various market factors on market segments and geographies.

Endotracheal Suctioning Devices Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current, and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint

Lip augmentation is a cosmetic procedure that is used to alter the appearance of the lips. Lip fillers and fat injections are alternatives to lip implant for lip augmentation. Lip implants are a form of lip enhancement that generally involve creating small incisions in the corners of the mouth. From there the plastic surgeons insert implants into the lips. There are various forms of implants that can be used including a patient’s skin or tissue, saline, or silicone.

Lip implants are generally made from a soft, biodegradable substance which is used by patients who desire to see a noticeable increase in lip volume. Experienced aesthetic surgeons usually execute lip implant surgery using local anesthesia and insert the lip implant through tiny incisions in the corners of the mouth. The non-surgical options like injectable lip fillers and collagen fillers are generally considered safe and require minimal anesthesia. Whereas lip implants are temporary and expensive with results lasting for many years. Lip implant has a smooth surface that reduces the chance of tissue growth. Lip implant is available in a variety of sizes in order to achieve customized results.  Some of the popular lip implants are GORE-TEX, SoftForm, and Ultrasoft with more recent product launches including FulFil and Permalip.

Lip implant sometimes cause serious side effects like allergic reactions, infections, implant shifting, prolonged swelling, or lip asymmetry. Patients might experience bruising and swelling following the surgery. It is often difficult to remove the lip implant after the procedure. The implants are non-reactive, meaning that there is no rejection of the implant.   

Lip Implant Market: Drivers and Restraints

The global lip implant market has seen impressive growth in the forecast period due to the increasing number of surgical cosmetic procedures. With lip augmentation procedures continuing to rise year on year, and patients becoming more savvy in seeking long term lip enhancement solutions that don’t require top-up treatments. However, lip implants aren’t used much these days due to the greater risk of side effects. The reduction in the adoption of the lip implant might deter the growth of the global lip implant market.

Lip Implant Market: Segmentation

The global lip implant market is segmented by material type, indication, end user and region:

Based on material type, the global lip implant market is segmented into:

• Gore-Tex
• AlloDerm
• Expanded Polytetrafluoroethylene (ePTFE)
• Soft Silicone Rubber
• Others

Based on the end user, the global lip implant market is segmented into:

• Hospitals
• Specialty Clinics
• Others

Lip Implant Market: Overview

Lip implants are soft silicone implants inserted to add volume into the lips. Lip implants with different lengths and thicknesses are available in the market. Lip implants are permanent and do not require any future follow-ups from the plastic surgeon as required in lip injections. Implantation of a lip implant is generally more costly than lip fillers, and over time they might be a more cost-effective procedure. Each lip implant costs between US$ 1,500 to US$ 3,000. Lip implants provide a semi-permanent lip enhancement for people who are desiring for a more lasting solution with minimal maintenance. Based on the end user, the global lip implant market is segmented into hospitals, specialty clinics, and others.

Lip Implant Market: Regional Outlook

North America leads the lip implant market due to the presence of leading players and increased number of cosmetic surgical procedures. Around 28,500 lip augmentation procedures were done in 2016, which is a 53% increase from 2000.  Europe is expected to hold the second highest market share in the global lip implant market. Manufacturers are majorly focusing on targeting the emerging markets due to the rise in cosmetic surgical procedures in the region. China lip implant market is one of the most lucrative markets in the Asia-Pacific region due to the growing demands for surgical cosmetic procedures in the region.

Lip Implant Market: Key Players

Examples of some of the key players in the global lip implant market are SurgiSil, L.L.P., Surgisol, W. L. Gore & Associates, Inc., LifeCell Corporation, Collagen Aesthetics Inc., and others.

The report covers exhaustive analysis on:

• Lip Implant Market  Segments
• Lip Implant Market  Dynamics
• Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
• China
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance

A pressure injury is also known as decubitus ulcers or pressure ulcer, and pressure sores which generally causes distortion of skin and tissue. Pressure is recognized as the main factor in the development of pressure injuries, with pressure three to five times higher internally near a bony prominence. Pressure injuries are usually caused due to the lack of poor nutrition, friction, aging skin, less mobility, moisture, etc. A pressure injury is formed in a localized area of the skin, underlying subcutaneous tissue over bone. Once the skin gets exposed to prolong pressure starved with proper oxygen and nutrients, the tissue becomes damaged leading to pressure injury. Thus, pressure injury prevention devices and therapies are being developed in order to treat pressure injuries. 

Pressure injuries are largely preventable but are generally recognized as a potentially life-threatening condition. Patient injury prevention is considered as an important area of patient safety. Boosting patient participation in care is an increasing trend observed in healthcare as it can upsurge adherence to treatment plans and improve outcomes. Pressure injuries are painful and result in decreased physical function and quality of life. In the U.S., Medicare hospitals no longer receive higher Medicare payments related to pressure injury prevention who acquire Stage III-IV pressure injuries during the inpatient stay.

Pressure Injury Prevention Market: Drivers and Restraints

Over time, pressure injury has become acute and is significantly causing a burden to the healthcare system. The healthcare spending burden on pressure injury is also increasing gradually. For instance, in the U.S. the cost for the healthcare system is around US$9 to11 billion per year. With the increasing aging population, the prevalence and incidence rate of pressure injury is also growing which is fueling the growth of the global pressure injury prevention market. The rising number of the elderly population, increase in incontinence in urine and obesity, and the dearth of poor nutrition will contribute to driving the growth of global pressure injury prevention market. Other factors responsible for driving the growth of the global pressure injury prevention market are growing diabetic population, peripheral arterial disease, kidney failure, heart failure, and others which makes the skin to be more fragile or delicate causing movement problems. Evolving innovations to heal pressure injuries using gene therapy which includes growth factors, and cytokines, adipose tissue or bone marrow-derived stem cell therapy might restrain the market growth of pressure injury prevention.

Pressure Injury Prevention Market: Segmentation

The global pressure injury prevention market is segmented by product type, end-user and region:

Based on product type, the global pressure injury prevention market is segmented into:

• Mattresses
• Protectors
• Cushions
• Offloading Footwear
• Patients Positioners

Based on the end-user, the global pressure injury prevention market is segmented into:

• Hospital
• Nursing Homes
• Home Care Settings
• Ambulatory Surgical Centers

Pressure Injury Prevention Market: Overview

A pressure injury is a very common issue observed in many hospitals. Many physiological factors like gender, age, race, weight, mobility have given rise to pressure injuries. The reimbursement is no longer being provided in many hospitals for pressure injury prevention. Due to the massive clinical need and lack of effective treatment, new technologies are being developed which are boosting the growth of pressure injury prevention market.

Pressure Injury Prevention Market: Regional Outlook

The Asia Pacific pressure injury prevention market is expected to grow with the maximum growth rate in the global pressure injury prevention market. The significant economic development in the Asia Pacific region has led to an increase in healthcare availability with a rise in the number of diabetic population and lack of poor nutrition. North America is anticipated to exhibit substantial growth in the pressure injury prevention market due to the presence of advanced healthcare facilities which as a result have a high impact in overall pressure injury prevention market. Europe pressure injury prevention market is anticipated to hold the second highest market share in the global pressure injury prevention market due to the increasing burden of pressure injuries and rising costs in healthcare. The developing countries of Latin America pressure injury prevention market and the Middle East and Africa pressure injury prevention market are projected to grow with a significant growth rate over the forecast period.  

Pressure Injury Prevention Market: Key Players

Examples of some of the key players in the global pressure injury prevention market are Sage Products LLC, Medi-Tech International Corp., TexMedico Inc., EHOB, Inc., 3M Company, Osborn Medical, Crawford Healthcare Limited, Invacare Corp., Hill-Rom, Inc., Arjo AB and others.

The report covers exhaustive analysis on:

• Pressure Injury Prevention Market  Segments
• Pressure Injury Prevention Market  Dynamics
• Pressure Injury Prevention Market Size
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Value Chain

The regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
• Eastern Europe (Poland, Russia)
• Asia-Pacific Excluding China and Japan (India, ASEAN, Australia & New Zealand)
• China
• Japan
• The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance